MT-103 (Medisyn Technologies)

N/A

Report date: 2022/12/29 11:27:21
NME

Base Information

Drug NameMT-103 (Medisyn Technologies)
Drug Alias NameMT-103 (Medisyn Technologies)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUndefined mechanism
TargetsNot applicable
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A